{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:mesenteric:mvt-001-definition",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T05:35:00.000Z",
    "modified": "2026-01-05T05:35:00.000Z",
    "contributors": ["copilot-agent"],
    "confidence": 0.92,
    "status": "validated",
    "maturity": "stable",
    "source_references": [
      "Rutherford's Vascular Surgery, 9th Edition",
      "SVS Clinical Practice Guidelines",
      "Journal of Vascular Surgery"
    ]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/mesenteric-venous-thrombosis",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Mesenteric Venous Thrombosis",
    "definition": "Thrombosis of the mesenteric venous system (SMV, IMV, portal vein) causing intestinal congestion, ischemia, and potentially infarction. Represents 5-15% of acute mesenteric ischemia cases with a distinct pathophysiology and better prognosis than arterial causes.",
    "clinical_features": {
      "presentation": {
        "symptoms": [
          "Abdominal pain (often insidious onset over days to weeks)",
          "Nausea and vomiting",
          "Diarrhea (sometimes bloody)",
          "Abdominal distension",
          "Anorexia"
        ],
        "signs": [
          "Abdominal tenderness (may be diffuse)",
          "Guarding and rebound (late findings)",
          "Fever",
          "Hypotension and tachycardia (if advanced)",
          "Hematochezia or melena"
        ]
      },
      "classification": {
        "acute_mvt": "Symptoms < 4 weeks, highest risk of intestinal infarction",
        "subacute_mvt": "Symptoms 4-12 weeks, collateral formation may occur",
        "chronic_mvt": "Asymptomatic or portal hypertension sequelae"
      },
      "etiology": {
        "hypercoagulable_states": [
          "Factor V Leiden (most common inherited)",
          "Prothrombin G20210A mutation",
          "Protein C, S, or antithrombin deficiency",
          "Antiphospholipid syndrome",
          "Myeloproliferative neoplasms (JAK2 mutation)"
        ],
        "local_factors": [
          "Pancreatitis",
          "Intra-abdominal sepsis",
          "Inflammatory bowel disease",
          "Abdominal surgery",
          "Cirrhosis and portal hypertension",
          "Malignancy (pancreatic, hepatic)"
        ],
        "medications": [
          "Oral contraceptives",
          "Hormone replacement therapy"
        ]
      },
      "diagnostic_criteria": {
        "imaging": {
          "ct_findings": [
            "Thrombus in SMV/portal vein (filling defect)",
            "Bowel wall thickening and edema",
            "Mesenteric fat stranding",
            "Ascites",
            "Pneumatosis intestinalis (late, ominous)",
            "Portal venous gas (late, ominous)"
          ],
          "target_sign": "Enhancing bowel wall around low-density center"
        },
        "laboratory": {
          "findings": [
            "Leukocytosis",
            "Elevated D-dimer",
            "Elevated lactate (late)",
            "Metabolic acidosis (late)"
          ],
          "hypercoagulable_workup": "Indicated in all cases without clear provoking factor"
        }
      }
    },
    "management": {
      "anticoagulation": {
        "initial": "IV heparin (UFH or LMWH)",
        "long_term": "Warfarin or DOAC for 3-6 months minimum",
        "indefinite": "If underlying hypercoagulable state or recurrent"
      },
      "surgical_indications": [
        "Peritonitis",
        "Bowel infarction/necrosis",
        "Clinical deterioration despite anticoagulation"
      ],
      "interventional_options": [
        "Catheter-directed thrombolysis (acute cases)",
        "Mechanical thrombectomy",
        "TIPS (in chronic portal vein thrombosis)"
      ],
      "second_look_laparotomy": "Consider if borderline bowel viability at initial surgery"
    },
    "prognosis": {
      "mortality": "10-20% (better than arterial mesenteric ischemia)",
      "factors_affecting_outcome": [
        "Time to diagnosis",
        "Extent of thrombosis",
        "Presence of bowel infarction",
        "Underlying etiology"
      ]
    },
    "codes": {
      "snomed_ct": "19890002 | Mesenteric vein thrombosis",
      "icd_10": "K55.0 | Acute vascular disorders of intestine"
    }
  },
  "relationships": {
    "skos:broader": [
      "vascular:mesenteric:acute-mesenteric-ischemia"
    ],
    "skos:related": [
      "vascular:mesenteric:chronic-mesenteric-ischemia",
      "vascular:thrombophilia",
      "vascular:portal-vein-thrombosis",
      "vascular:pharmacology:anticoagulation"
    ],
    "skos:narrower": []
  },
  "pedagogical_content": {
    "clinical_pearls": [
      "MVT has more insidious onset than arterial mesenteric ischemia - pain out of proportion to exam is less dramatic",
      "Always order hypercoagulable workup - up to 80% have identifiable prothrombotic condition",
      "JAK2 mutation testing important - may reveal occult myeloproliferative neoplasm",
      "CT with IV contrast is diagnostic - look for portal/SMV filling defects",
      "Anticoagulation alone sufficient in most cases without bowel infarction"
    ],
    "learning_objectives": [
      "Distinguish MVT from arterial mesenteric ischemia by presentation timing",
      "Identify CT findings diagnostic of MVT",
      "Understand indications for surgery vs anticoagulation",
      "Know when to order hypercoagulable workup"
    ],
    "board_review_points": [
      "MVT = most insidious onset of mesenteric ischemia types",
      "Factor V Leiden = most common inherited cause",
      "Treatment = anticoagulation unless peritonitis/infarction",
      "JAK2 mutation should be checked in all unexplained MVT"
    ]
  }
}
